Physician profile
Timothy Overlock
NPI 1194722173
$3,126.87
in general payments reported to CMS, 2019-2025
33 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $347 · 2020: $641 · 2021: $916 · 2022: $428 · 2023: $256 · 2024: $412 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $572.66 | 2019-2025 | Trelegy Ellipta |
| Lilly USA, LLC | $420.34 | 2019-2025 | Jardiance, Trulicity, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $241.73 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $234.33 | 2022-2024 | Jardiance, Synjardy |
| Abbott Laboratories | $197.87 | 2021-2024 | Freestyle Libre 3 |
| Sanofi-Aventis U.S. LLC | $145.50 | 2019-2022 | |
| Pfizer INC. | $125.45 | 2019-2022 | |
| Amgen INC. | $112.72 | 2019-2024 | Prolia, Evenity |
| Novo Nordisk INC | $111.20 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $104.74 | 2019-2023 | |
| Allergan, INC. | $91.67 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $83.55 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $75.27 | 2020-2025 | Capvaxive |
| Abbvie INC. | $74.32 | 2021 | |
| Esperion Therapeutics, INC. | $65.13 | 2020-2024 | Nexletol |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $64.45 | 2021 | |
| Mannkind Corporation | $59.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $54.72 | 2022 | |
| Inspire Medical Systems, INC. | $39.07 | 2025 | Inspire |
| Paratek Pharmaceuticals, INC. | $36.98 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $29.23 | 2019 | |
| Mylan Specialty L.P. | $21.58 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $18.18 | 2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.72 | 2022 | |
| Astellas Pharma US INC | $16.49 | 2019 | |
| Phathom Pharmaceuticals, INC. | $16.44 | 2024 | Voquezna |
| Eisai INC. | $15.62 | 2024 | |
| Medtronic Minimed, INC. | $15.35 | 2019 | |
| Arbor Pharmaceuticals, INC. | $14.61 | 2021 | |
| Irhythm Technologies, INC. | $14.45 | 2023 | Zio Xt Patch |
| Horizon Therapeutics Plc | $13.19 | 2021 | |
| Dexcom, INC. | $12.33 | 2022 | |
| Bardy Diagnostics, INC. | $10.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Overlock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.